Evidence map›Paper›PMID 10822379›Full record

ArticleOncogene2000

Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2.

J Häcki, L Egger, L Monney, S Conus, T Rossé, I Fellay, C Borner

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 299 citations in OpenAlex.

  1. Article
  2. Dolutegravir induces endoplasmic reticulum stress at the blood-brain barrier.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A mini review of fluoride-induced apoptotic pathways.Environmental science and pollution research international · 2018
    Review
  12. Review
  13. Article
  14. Article
  15. Inflammatory diseases modelling in zebrafish.World journal of experimental medicine · 2016
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Serum Bcl-2 Levels in Patients with β-Thalassemia Minor: A Pilot Study.Turkish journal of haematology : official journal of Turkish Society of Haematology · 2014
    Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

J HäckiInstitute of Biochemistry, University of Fribourg, Switzerland.
L Egger
L Monney
S Conus
T Rossé
I Fellay
C Borner
University of Fribourg · CHHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apoptosis involves mitochondrial steps such as the release of the apoptogenic factor cytochrome c which are effectively blocked by Bcl-2. Although Bcl-2 may have a direct action on the mitochondrial membrane, it also resides and functions on the endoplasmic reticulum (ER), and there is increasing evidence for a role of the ER in apoptosis regulation as well. Here we uncover a hitherto unrecognized, apoptotic crosstalk between the ER and mitochondria that is controlled by Bcl-2. After triggering massive ER dilation due to an inhibition of secretion, the drug brefeldin A (BFA) induces the release of cytochrome c from mitochondria in a caspase-8- and Bid-independent manner. This is followed by caspase-3 activation and DNA/nuclear fragmentation. Surprisingly, cytochrome c release by BFA is not only blocked by wild-type Bcl-2 but also by a Bcl-2 variant that is exclusively targeted to the ER (Bcl-2/cb5). Similar findings were obtained with tunicamycin, an agent interfering with N-linked glycosylations in the secretory system. Thus, apoptotic agents perturbing ER functions induce a novel crosstalk between the ER and mitochondria that can be interrupted by ER-based Bcl-2.

Indexed as

Amino Acid Chloromethyl KetonesAnimalsAnti-Bacterial AgentsApoptosisBiological TransportB-LymphocytesBrefeldin ACaspase 3Caspase 8Caspase 9Caspase InhibitorsCaspasesCell NucleusCoumarinsCycloheximideCysteine Proteinase Inhibitorsacetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarinAmino Acid Chloromethyl KetonesAnti-Bacterial Agentsbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneBrefeldin ACASP3 protein, humanCasp3 protein, ratCASP8 protein, humanCasp8 protein, ratCASP9 protein, humanCasp9 protein, ratCaspase 3Caspase 8Caspase 9Caspase InhibitorsCaspasesCoumarinsCycloheximideCysteine Proteinase InhibitorsCytochrome c GroupOligopeptidesProtein Synthesis InhibitorsProto-Oncogene Proteins c-bcl-2Tunicamycin

Identifiers

PMID10822379
OpenAlexW2013065884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.